Trial · NCT00345176
Adverse events132
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 132
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Dry eye | Eye disorders | Placebo/Control | 55 | 1,012 | 62 |
| other | Dry eye | Eye disorders | Lutein/Zeaxanthin | 39 | 1,044 | 40 |
| other | Dry eye | Eye disorders | DHA/EPA | 64 | 1,068 | 70 |
| other | Dry eye | Eye disorders | Lutein/Zeaxanthin + DHA/EPA | 62 | 1,079 | 70 |
| other | Eye disorder | Eye disorders | Placebo/Control | 67 | 1,012 | 100 |
| other | Eye disorder | Eye disorders | Lutein/Zeaxanthin | 67 | 1,044 | 96 |
| other | Eye disorder | Eye disorders | DHA/EPA | 62 | 1,068 | 98 |
| other | Eye disorder | Eye disorders | Lutein/Zeaxanthin + DHA/EPA | 82 | 1,079 | 152 |
| other | Visual disturbance | Eye disorders | Placebo/Control | 88 | 1,012 | 118 |
| other | Visual disturbance | Eye disorders | Lutein/Zeaxanthin | 110 | 1,044 | 139 |
| other | Visual disturbance | Eye disorders | DHA/EPA | 84 | 1,068 | 116 |
| other | Visual disturbance | Eye disorders | Lutein/Zeaxanthin + DHA/EPA | 88 | 1,079 | 119 |
| other | Vitreous disorder | Eye disorders | Placebo/Control | 133 | 1,012 | 208 |
| other | Vitreous disorder | Eye disorders | Lutein/Zeaxanthin | 154 | 1,044 | 213 |
| other | Vitreous disorder | Eye disorders | DHA/EPA | 165 | 1,068 | 228 |
| other | Vitreous disorder | Eye disorders | Lutein/Zeaxanthin + DHA/EPA | 162 | 1,079 | 208 |
| other | Change in bowel habit | Gastrointestinal disorders | Placebo/Control | 57 | 1,012 | 69 |
| other | Change in bowel habit | Gastrointestinal disorders | Lutein/Zeaxanthin | 67 | 1,044 | 77 |
| other | Change in bowel habit | Gastrointestinal disorders | DHA/EPA | 48 | 1,068 | 58 |
| other | Change in bowel habit | Gastrointestinal disorders | Lutein/Zeaxanthin + DHA/EPA | 57 | 1,079 | 60 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00345176/events